entertainment -WSS

entertainment

author：explore 2025-08-03 10:46:55 - browse：26749

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Illinois Supreme Court finds assault weapons ban constitutional

knowledge

WSS

Health AI: on the border between health care and tech

NIH study of ME/CFS points to clear biological hallmarks

With competition flaring, obesity drug hits goal in liver disease study

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Novo Nordisk touts Wegovy study, but still struggling with supply

Be careful with at

knowledge

entertainment

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Bird flu researchers hone in on Finland’s mink farms

Hollywood unions extend contract negotiations for actors

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

The cancer drug shortage isn’t new — and neither are the solutions

Maui wildfire now ranks as the fifth

Malaria cases in Florida and Texas: Here’s what you need to know

Schizophrenia gene found to be linked to cells' energy dysfunction

As demand for Covid shots wanes, Moderna seeks its next success

Novo Nordisk touts Wegovy study, but still struggling with supply

leisure time

Maui wildfire now ranks as the fifth

A new nitrogen execution bill also undermines medical licensing

Montana youths win climate lawsuit against state for promoting fossil fuels

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Mark Cuban is blaming the wrong people for high drug costs

PBM reform efforts get punted in Congress

focus

explore

knowledge

focus